# K061125: Dvtcare CA5

- Pathway: 510(k) (Traditional)
- Applicant: Doctors Orders
- Decided: May 23, 2006 after 29 days
- Product code: JOW (Sleeve, Limb, Compressible)
- Device class: 2
- Regulation: 21 CFR 870.5800
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 2 generations back to K915638 (1992). 6 ancestors in all.
30 later devices descend from it; 8 cite it directly.
0 of 37 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K023573: Wizair Compression System, Medical Compression Systems (Dbn), Ltd. (2002) Summary page 2.
- K022340: Travelair Portable Compression System, Dynamic Air, Inc. (2003) Summary page 2.
- K011318: Venodyne DVT Advantage Plus, Microtek Medical, Inc. (2001)
- K961166: Flowtron Excel Pump, Hne Healthcare, Inc. (1996) Summary page 3.

## Most influential descendants
- K103187: Tripleplay-VT Vascular Therapy System (2011), 25 descendants of its own
- K133274: Vena Pro (2014), 22 descendants of its own
- K151189: Cirona 6300 Disposable Deep Vein Thrombosis (DVT) Prevention System (2015), 5 descendants of its own
- K160318: PlasmaFlow (2016), 4 descendants of its own
- K193020: VenaPro Vascular Therapy System (2019), 2 descendants of its own

## Indications for use
The DVTcareTM CA5 is intended to be an easy to use, portable system that is prescribed by healthcare professionals, to help prevent the onset of DVT in patients, by stimulating blood flow in the legs (simulating muscle contractions). Furthermore, the unit can be used as an aid in the prophylaxis for DVT by persons traveling, or those expecting to be stationary for long periods of time (> 4 hours). This device can also be used to: aid in the prevention of DVT, enhance blood circulation, diminish post-operative pain and swelling, reduce wound healing time, and aid in the treatment and healing of stasis dermatitis, venous stasis ulcers, arterial and diabetic leg ulcers, chronic venous insufficiency, and reduction of edema in the lower limbs.

Source page: https://510kreport.com/device/K061125
Methodology: https://510kreport.com/methodology
